[Clinical, immunophenotypic and cell cyclic analysis in chronic lymphocytic leukemia]

Area of Science:

• Hematology
• Immunology
• Oncology

Context:

• Chronic lymphocytic leukemia (CLL) is a heterogeneous lymphoid malignancy.
• Accurate immunophenotyping is crucial for CLL subclassification and understanding disease biology.
• Previous studies have established B-CLL as the predominant subtype.

Purpose:

• To immunophenotypically characterize 15 cases of chronic lymphocytic leukemia (CLL).
• To differentiate between B-cell CLL (B-CLL) and T-cell CLL (T-CLL) subtypes.
• To analyze cell cycle distribution and potential for prolymphocytoid transformation in CLL.

Summary:

• Fifteen CLL cases were analyzed using monoclonal antibodies.
• Thirteen cases were identified as B-CLL, characterized by CD20+, HLA-Dr+, SmIg+, and CD5+/Em+.
• Two cases were classified as T-CLL, with one exhibiting a Ts phenotype and the other HLA-Dr+ T-CLL.
• Bone marrow analysis showed a higher ratio of G0+G1 cells (91.1%) and lower S+G2M cells (8.9%) in CLL patients compared to controls.
• Cell cycle ratios were consistent between bone marrow and peripheral blood.
• Prolymphocytoid transformation occurred in three patients during late-stage disease.

Impact:

• This research aids in distinguishing B-CLL from rarer T-CLL subtypes through specific immunophenotypic markers.
• Understanding cell cycle kinetics provides insights into CLL proliferation and disease progression.
• The identification of prolymphocytoid transformation highlights a potential clinical evolution pathway in CLL.
• Results contribute to a more comprehensive understanding of CLL heterogeneity and its clinical implications.